Exact Mass: 504.2042452
Exact Mass Matches: 504.2042452
Found 274 metabolites which its exact mass value is equals to given mass value 504.2042452
,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
Chlorhexidine
C22H30Cl2N10 (504.20318399999996)
Chlorhexidine is only found in individuals that have used or taken this drug. It is a disinfectant and topical anti-infective agent used also as mouthwash to prevent oral plaque. [PubChem]Chlorhexidines antimicrobial effects are associated with the attractions between chlorhexidine (cation) and negatively charged bacterial cells. After chlorhexidine is absorpted onto the organisms cell wall, it disrupts the integrity of the cell membrane and causes the leakage of intracellular components of the organisms. A - Alimentary tract and metabolism > A01 - Stomatological preparations > A01A - Stomatological preparations > A01AB - Antiinfectives and antiseptics for local oral treatment B - Blood and blood forming organs > B05 - Blood substitutes and perfusion solutions > B05C - Irrigating solutions > B05CA - Antiinfectives D - Dermatologicals > D08 - Antiseptics and disinfectants > D08A - Antiseptics and disinfectants > D08AC - Biguanides and amidines D - Dermatologicals > D09 - Medicated dressings > D09A - Medicated dressings > D09AA - Medicated dressings with antiinfectives S - Sensory organs > S03 - Ophthalmological and otological preparations > S03A - Antiinfectives > S03AA - Antiinfectives R - Respiratory system > R02 - Throat preparations > R02A - Throat preparations > R02AA - Antiseptics S - Sensory organs > S02 - Otologicals > S02A - Antiinfectives > S02AA - Antiinfectives S - Sensory organs > S01 - Ophthalmologicals > S01A - Antiinfectives C254 - Anti-Infective Agent > C28394 - Topical Anti-Infective Agent D007004 - Hypoglycemic Agents > D001645 - Biguanides D003358 - Cosmetics > D009067 - Mouthwashes D001697 - Biomedical and Dental Materials D000890 - Anti-Infective Agents D004202 - Disinfectants
Myricatomentoside I
Myricatomentoside I is found in herbs and spices. Myricatomentoside I is a constituent of Myrica gale var. tomentosa
Hiyodarilactone F
(Z)-5?-hydroxyjasmone5?-O-{6??-O-[(E)-caffeoyl]-beta-D-glucopyranoside}|2-[(2Z)-5-[[6-O-[(2E)-3-(3,4-dihydroxyphenyl)-1-oxoprop-2-en-1-yl]-beta-D-glucopyranosyl]oxy]pent-2-en-1-yl]-3-methyl-2-cyclopenten-1-one
(3S)-8-[(6-O-acetyl-beta-D-glucopyranosyl)oxy]-3-[(1E,3E,5E)-hepta-1,3,5-trienyl]-3,4-dihydro-6-methoxy-5-methyl-1H-2-benzopyran-1-one|(3S,11E,13E,15E)-8-[(6-O-acetyl-beta-D-glucopyranosyl)oxy]-3-heptatrienyl-6-methoxy-5-methylisochroman-1-one
(2S,3S)-2-(5-methoxy-3,4-methylenedioxybenzyl)-3-(4-hydroxy-3,5-dimethoxybenzyl)butane-1,4-diol diacetate
Ala Asp His Tyr
Ala Asp Asn Trp
Ala Asp Trp Asn
Ala Asp Tyr His
Ala His Asp Tyr
Ala His Tyr Asp
Ala Asn Asp Trp
Ala Asn Trp Asp
Ala Trp Asp Asn
Ala Trp Asn Asp
Ala Tyr Asp His
Ala Tyr His Asp
Asp Ala His Tyr
Asp Ala Asn Trp
Asp Ala Trp Asn
Asp Ala Tyr His
Asp Glu Glu Ile
Asp Glu Glu Leu
Asp Glu Ile Glu
Asp Glu Leu Glu
Asp Phe His Ser
Asp Phe Ser His
Asp Gly Gln Trp
Asp Gly Trp Gln
Asp His Ala Tyr
Asp His Phe Ser
Asp His His Pro
Asp His Pro His
Asp His Ser Phe
Asp His Tyr Ala
Asp Ile Glu Glu
Asp Leu Glu Glu
Asp Asn Ala Trp
Asp Asn Trp Ala
Asp Pro His His
Asp Gln Gly Trp
Asp Gln Trp Gly
Asp Ser Phe His
Asp Ser His Phe
Asp Trp Ala Asn
Asp Trp Gly Gln
Asp Trp Asn Ala
Asp Trp Gln Gly
Asp Tyr Ala His
Asp Tyr His Ala
Glu Asp Glu Ile
Glu Asp Glu Leu
Glu Asp Ile Glu
Glu Asp Leu Glu
Glu Glu Asp Ile
Glu Glu Asp Leu
Glu Glu Glu Val
Glu Glu Ile Asp
Glu Glu Leu Asp
Glu Glu Val Glu
Glu Gly His Tyr
Glu Gly Asn Trp
Glu Gly Trp Asn
Glu Gly Tyr His
Glu His Gly Tyr
Glu His Tyr Gly
Glu Ile Asp Glu
Glu Ile Glu Asp
Glu Leu Asp Glu
Glu Leu Glu Asp
Glu Asn Gly Trp
Glu Asn Trp Gly
Glu Val Glu Glu
Glu Trp Gly Asn
Glu Trp Asn Gly
Glu Tyr Gly His
Glu Tyr His Gly
Phe Asp His Ser
Phe Asp Ser His
Phe His Asp Ser
Phe His Ser Asp
Phe Ser Asp His
Phe Ser His Asp
Gly Asp Gln Trp
Gly Asp Trp Gln
Gly Glu His Tyr
Gly Glu Asn Trp
Gly Glu Trp Asn
Gly Glu Tyr His
Gly Gly Trp Trp
Gly His Glu Tyr
Gly His Tyr Glu
Gly Asn Glu Trp
Gly Asn Trp Glu
Gly Gln Asp Trp
Gly Gln Trp Asp
Gly Trp Asp Gln
Gly Trp Glu Asn
Gly Trp Gly Trp
Gly Trp Asn Glu
Gly Trp Gln Asp
Gly Trp Trp Gly
Gly Tyr Glu His
Gly Tyr His Glu
His Ala Asp Tyr
His Ala Tyr Asp
His Asp Ala Tyr
His Asp Phe Ser
His Asp His Pro
His Asp Pro His
His Asp Ser Phe
His Asp Tyr Ala
His Glu Gly Tyr
His Glu Tyr Gly
His Phe Asp Ser
His Phe Ser Asp
His Gly Glu Tyr
His Gly Tyr Glu
His His Asp Pro
His His Pro Asp
His Pro Asp His
His Pro His Asp
His Ser Asp Phe
His Ser Phe Asp
His Tyr Ala Asp
His Tyr Asp Ala
His Tyr Glu Gly
His Tyr Gly Glu
Ile Asp Glu Glu
Ile Glu Asp Glu
Ile Glu Glu Asp
Leu Asp Glu Glu
Leu Glu Asp Glu
Leu Glu Glu Asp
Asn Ala Asp Trp
Asn Ala Trp Asp
Asn Asp Ala Trp
Asn Asp Trp Ala
Asn Glu Gly Trp
Asn Glu Trp Gly
Asn Gly Glu Trp
Asn Gly Trp Glu
Asn Trp Ala Asp
Asn Trp Asp Ala
Asn Trp Glu Gly
Asn Trp Gly Glu
Pro Asp His His
Pro His Asp His
Pro His His Asp
Gln Asp Gly Trp
Gln Asp Trp Gly
Gln Gly Asp Trp
Gln Gly Trp Asp
Gln Trp Asp Gly
Gln Trp Gly Asp
Ser Asp Phe His
Ser Asp His Phe
Ser Phe Asp His
Ser Phe His Asp
Ser His Asp Phe
Ser His Phe Asp
Val Glu Glu Glu
Trp Ala Asp Asn
Trp Ala Asn Asp
Trp Asp Ala Asn
Trp Asp Gly Gln
Trp Asp Asn Ala
Trp Asp Gln Gly
Trp Glu Gly Asn
Trp Glu Asn Gly
Trp Gly Asp Gln
Trp Gly Glu Asn
Trp Gly Gly Trp
Trp Gly Asn Glu
Trp Gly Gln Asp
Trp Gly Trp Gly
Trp Asn Ala Asp
Trp Asn Asp Ala
Trp Asn Glu Gly
Trp Asn Gly Glu
Trp Gln Asp Gly
Trp Gln Gly Asp
Trp Trp Gly Gly
Tyr Ala Asp His
Tyr Ala His Asp
Tyr Asp Ala His
Tyr Asp His Ala
Tyr Glu Gly His
Tyr Glu His Gly
Tyr Gly Glu His
Tyr Gly His Glu
Tyr His Ala Asp
Tyr His Asp Ala
Tyr His Glu Gly
Tyr His Gly Glu
Myricatomentoside I
Labetalol Metabolite (b-D-Glucopyranosiduronic acid, 1-[3-(aminocarbonyl)-4-hydroxyphenyl]-2-[(1-met
C25H32N2O9 (504.21077019999996)
Labetalol Metabolite (b-D-Glucopyranosiduronic acid, 2-(aminocarbonyl)-4-[1-hydroxy-2-[(1-methyl-3-p
C25H32N2O9 (504.21077019999996)
Berkeleylactone B
Tofacitinib Citrate
C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor D004791 - Enzyme Inhibitors > D047428 - Protein Kinase Inhibitors > D000075242 - Janus Kinase Inhibitors C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C1967 - Tyrosine Kinase Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor > C172200 - JAK Inhibitor
Samidorphan L-malate
C25H32N2O9 (504.21077019999996)
C78272 - Agent Affecting Nervous System > C681 - Opiate Antagonist
Ala-Trp-Asn-Asp
A tetrapeptide composed of L-alanine, L-tryptophan, L-asparagine, and L-aspartic acid joined in sequence by peptide linkages.
4-[2-(Cyclohexylamino)-2-oxo-1-[(1-oxo-2-thiophen-2-ylethyl)-(phenylmethyl)amino]ethyl]benzoic acid methyl ester
N-[(2S,3R)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl(methylsulfonyl)amino]methyl]-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]-4-pyridinecarboxamide
N-[(2S,3S)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl(methylsulfonyl)amino]methyl]-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]-4-pyridinecarboxamide
N-[(2R,3S)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl(methylsulfonyl)amino]methyl]-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]-4-pyridinecarboxamide
N-[(2R,3R)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl(methylsulfonyl)amino]methyl]-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]-4-pyridinecarboxamide
(2S,3S,4S,5R)-6-[1-(3-carbamoyl-4-hydroxyphenyl)-2-(4-phenylbutan-2-ylamino)ethoxy]-3,4,5-trihydroxyoxane-2-carboxylic acid
C25H32N2O9 (504.21077019999996)
Chlorhexidine
C22H30Cl2N10 (504.20318399999996)
A - Alimentary tract and metabolism > A01 - Stomatological preparations > A01A - Stomatological preparations > A01AB - Antiinfectives and antiseptics for local oral treatment B - Blood and blood forming organs > B05 - Blood substitutes and perfusion solutions > B05C - Irrigating solutions > B05CA - Antiinfectives D - Dermatologicals > D08 - Antiseptics and disinfectants > D08A - Antiseptics and disinfectants > D08AC - Biguanides and amidines D - Dermatologicals > D09 - Medicated dressings > D09A - Medicated dressings > D09AA - Medicated dressings with antiinfectives S - Sensory organs > S03 - Ophthalmological and otological preparations > S03A - Antiinfectives > S03AA - Antiinfectives R - Respiratory system > R02 - Throat preparations > R02A - Throat preparations > R02AA - Antiseptics S - Sensory organs > S02 - Otologicals > S02A - Antiinfectives > S02AA - Antiinfectives S - Sensory organs > S01 - Ophthalmologicals > S01A - Antiinfectives C254 - Anti-Infective Agent > C28394 - Topical Anti-Infective Agent D007004 - Hypoglycemic Agents > D001645 - Biguanides D003358 - Cosmetics > D009067 - Mouthwashes D001697 - Biomedical and Dental Materials D000890 - Anti-Infective Agents D004202 - Disinfectants
2-[11'-(acetyloxy)-7'-[(acetyloxy)methyl]-12'-methyl-8'-oxo-10'-oxaspiro[oxirane-2,6'-tricyclo[7.2.1.0²,⁷]dodecan]-1'-yl]-1-(furan-3-yl)ethyl acetate
(1s,2s,3r,8s,9z,11z,13s,14r,15s,17r,19s)-13,15-bis(acetyloxy)-5,10,14,19-tetramethyl-6-oxo-4,7,18-trioxapentacyclo[12.5.0.0³,⁵.0³,⁸.0¹⁷,¹⁹]nonadeca-9,11-dien-2-yl acetate
2-(acetyloxy)-5-(furan-3-yl)-3',13'-dimethyl-12',14',15',17'-tetraoxaspiro[oxolane-3,4'-pentacyclo[7.5.2.1⁹,¹³.0¹,¹⁰.0⁵,¹⁰]heptadecan]-8'-yl acetate
(6-{[3-(hepta-1,3,5-trien-1-yl)-6-methoxy-5-methyl-1-oxo-3,4-dihydro-2-benzopyran-8-yl]oxy}-3,4,5-trihydroxyoxan-2-yl)methyl acetate
(1s,2s,3r,5r,8s,9z,11z,13s,14r,15s,17r,19s)-13,15-bis(acetyloxy)-5,10,14,19-tetramethyl-6-oxo-4,7,18-trioxapentacyclo[12.5.0.0³,⁵.0³,⁸.0¹⁷,¹⁹]nonadeca-9,11-dien-2-yl acetate
2,5-dihydroxy-3-[6-(3-methylbut-2-en-1-yl)-1h-indol-3-yl]-6-[6-(3-methylbuta-1,3-dien-1-yl)-1h-indol-3-yl]cyclohexa-2,5-diene-1,4-dione
C32H28N2O4 (504.20489680000003)
2',2''-bis(acetyloxy)-5''-(furan-3-yl)-6'-methyl-8'-oxo-hexahydrodispiro[oxirane-2,1'-naphthalene-5',3''-oxolan]-8'a-ylmethyl acetate
2,5-dihydroxy-3-[6-(3-methylbut-2-en-1-yl)-1h-indol-3-yl]-6-{6-[(1e)-3-methylbuta-1,3-dien-1-yl]-1h-indol-3-yl}cyclohexa-2,5-diene-1,4-dione
C32H28N2O4 (504.20489680000003)